Larimar Therapeutics, Inc. (LRMR) Appoints John Harlow as President and COO

Larimar Therapeutics appointed John Harlow as President and Chief Operating Officer, effective Sept. 29, 2026. An inducement grant includes options for 800,000 shares and 50,000 RSUs, vesting over four years.Material DetailsContext by AI AnalystThis is a late-stage scaling move as Larimar readies n…